Publicacións en colaboración con investigadores/as de Hospital del Mar (4)

2023

  1. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121

2022

  1. Relationship between immunometabolic status and cognitive performance among major depression disorder patients

    Psychoneuroendocrinology, Vol. 137

2021

  1. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder

    Journal of Affective Disorders, Vol. 279, pp. 343-352

2018

  1. A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)

    European Neuropsychopharmacology, Vol. 28, Núm. 1, pp. 185-194